1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with Obesity in 1 studies
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grigsby, RJ | 1 |
| Dobrowsky, RT | 1 |
1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Obesity
| Article | Year |
|---|---|
Inhibition of ceramide production reverses TNF-induced insulin resistance.
Topics: 3T3 Cells; Adipocytes; Amino Acid Chloromethyl Ketones; Animals; Caveolae; Ceramides; Cysteine Prote | 2001 |